Open Nav

HPBIO Inc.

  • Jiyoung Ahn, HPBIO Inc.

investment and business partnering.

  • Date:Thursday, October 18
  • Time:10:00 AM - 10:15 AM
  • Room:Elizabethan A
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Theragnostics (Drug development) Company using Aptamer Technology.
  • Company Website:www.hpbio.co.kr
  • Company HQ City:SEOUL
  • Company HQ Country:Korea - South Korea
  • Main Therapeutic Focus:Gene/Cell Therapy
  • Lead Product in Development :Obesity
  • Development Phase of Primary Product:Pre-Clinical
  • Total Amount Raised to Date, In All Rounds:19~50 mil USD
Speakers
Jiyoung Ahn
HPBIO Inc.
Back